Early Phase 1 Multiple Sclerosis Trial, Not Yet Recruiting NCT07086950 Sponsor: Prof. Arseny Sokolov, MD, PhD Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Early Phase 1 Multiple Sclerosis Trial, Not Yet Recruiting

NCT07086950
Not Yet Recruiting Early Phase 1

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who have signed an informed consent form agreeing to take part in the trial.
  • People who are 18 years of age or older.
  • People who have been diagnosed with relapsing multiple sclerosis (a form of MS where symptoms come and go) or secondary progressive MS (a form where symptoms gradually worsen), with the secondary progressive diagnosis made no more than 30 months ago, as confirmed by their treating doctor.
  • People who have noticed problems with their thinking, memory, or concentration.
  • People who scored at a certain level on a thinking and processing speed test called the Symbol Digit Modalities Test, showing some difficulty in this area (confirm with trial site for exact score details).

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have had a confirmed MS relapse (a flare-up of symptoms) within the 3 months before enrolling.
  • People who have changed their MS treatment, antidepressant, or anti-anxiety medication within the month before enrolling.
  • People considered at high risk of falling, based on taking more than 15 seconds to complete a stepping balance test called the Four Square Step Test.
  • People who have needed assistance to walk or who have had a fall in the past 3 months, as assessed during the enrolment interview.
  • People who have been diagnosed with a major psychiatric condition or a significant neurocognitive disorder, as defined by current diagnostic guidelines.
  • People who are unable to tell colours apart, as tested by a standard colour vision test called the Ishihara test.
  • People who do not have enough knowledge of the language used in the trial to understand instructions or questionnaires.
  • People with a high-risk pregnancy, as determined by an appointed gynaecologist.
  • People who scored at an extremely low level on the Symbol Digit Modalities Test, indicating very severe difficulty with thinking and processing speed (confirm with trial site for exact score details).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Early Phase 1
Sponsor
Prof. Arseny Sokolov, MD, PhD
Registry
ClinicalTrials.gov
Start date
1 September 2025
Est. completion
30 June 2028

Primary endpoints

PDQ-20

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov